Kentucky Retirement Systems Insurance Trust Fund trimmed its stake in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 7.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,126 shares of the biotechnology company’s stock after selling 162 shares during the period. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Axon Enterprise were worth $850,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Empowered Funds LLC acquired a new stake in shares of Axon Enterprise during the first quarter worth about $340,000. Vanguard Group Inc. lifted its stake in Axon Enterprise by 2.7% in the first quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock valued at $2,547,878,000 after buying an additional 212,401 shares during the last quarter. Acadian Asset Management LLC acquired a new stake in shares of Axon Enterprise in the first quarter valued at approximately $2,137,000. Edgestream Partners L.P. purchased a new position in shares of Axon Enterprise during the first quarter worth approximately $1,043,000. Finally, Covestor Ltd increased its holdings in shares of Axon Enterprise by 18.4% in the 1st quarter. Covestor Ltd now owns 444 shares of the biotechnology company’s stock valued at $139,000 after acquiring an additional 69 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.
Axon Enterprise Stock Performance
Shares of AXON opened at $599.35 on Monday. The company has a market capitalization of $45.70 billion, a PE ratio of 154.87, a P/E/G ratio of 15.05 and a beta of 0.94. Axon Enterprise, Inc. has a 52-week low of $220.78 and a 52-week high of $624.84. The company has a 50-day simple moving average of $438.79 and a 200-day simple moving average of $357.90. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.
Wall Street Analyst Weigh In
Check Out Our Latest Analysis on AXON
Insider Activity
In other Axon Enterprise news, CEO Patrick W. Smith sold 80,300 shares of the business’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the sale, the chief executive officer now directly owns 3,015,366 shares in the company, valued at approximately $1,121,052,771.48. The trade was a 2.59 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction on Monday, September 16th. The shares were sold at an average price of $380.99, for a total value of $380,990.00. Following the completion of the transaction, the director now owns 27,259 shares of the company’s stock, valued at approximately $10,385,406.41. This represents a 3.54 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 411,006 shares of company stock worth $161,360,618. Company insiders own 6.10% of the company’s stock.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
- Five stocks we like better than Axon Enterprise
- What Makes a Stock a Good Dividend Stock?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- The Basics of Support and Resistance
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- What is the S&P/TSX Index?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.